Anindo C.

Oncology Drug Development @ Eli Lilly

Role
Director, Global Clinical Development, Oncology at Eli Lilly and Company
Location
Indianapolis, IN, US
LinkedIn followers
500 followers

About Anindo C.

Be human, it costs nothing” Clinical Scientist with demonstrated history working in pharmaceutical industry and academic research. Skilled in Cross-functional partnerships, Inclusive Leadership and Enterprise-Wide Strategy with a M.S. in Medical Biochemistry, a Ph.D. focused in Biochemistry, postdoctoral fellowships in Hematology/Oncology from National Institutes of Health (NIH) and the American Cancer Society and more than a decade of pharmaceutical drug development experience. Expertise in solid tumors and heme malignancies with a global footprint from preclinical to post-launch, with experience spanning commercial and payer strategies, medical affairs and clinical development- the path from bench to bedside. Undeterred focus on evidence-based medicine and its interpretation for optimal patient outcomes.Driven by a deep personal loss to the ravaging disease of cancer and propelled onto a life long journey to bring the best medicines to families and patients waiting eagerly for help “Inspire, so others can Aspire”

Experience

  1. Director, Global Clinical Development, Oncology

    Eli Lilly and Company

    Mar 2026 — Present · US

    Support Clinical development for breast cancer franchise.

Education

  • Purdue University

    Doctor of Philosophy (Ph.D.), Biochemistry

    2004 — 2010

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Anindo C. — Director, Global Clinical Development, Oncology at Eli Lilly and Company in Indianapolis, IN, US | Unifers